VC vs Entrepreneurs’ authored by Saurabh Mishra
19th October 2017 LABIOTECH.eu published ‘Negotiating early stage Biotech valuation: VC vs Entrepreneurs’ authored by Saurabh Mishra, Managing Partner, Farmantra. Read More
Talk on Early stage Valuation for CFA society Switzerland by Saurabh Mishra
4 July 2017 in Geneva, 5 July 2017 in Zurich : Saurabh Mishra, Partner at Farmantra volunteered to give a talk on Early stage Valuation for CFA society Switzerland.
Optimize your Value from Discovery to Commercialization
Oct 29, 2015 : Optimize your Value from Discovery to Commercialization Farmantra and Black Swan Consulting welcome you to attend our conference on October 29th on the following topic.
An Overview of Stem Cell Therapy
December 2012: An Overview of Stem Cell Therapy The stem cell market is expected to reach US $ 63.8 billion by 2015. Higher growth rate is expected from countries such as China, India, Spain, Greece and Sweden which are at…
Internationalization of Life Science Companies: The India paradigm
June 2012: We are pleased to share the news regarding our first conference organized on 7th June 2012 with the collaboration of Biocat and Barcelonactiva. The theme of the conference was: ‘Internationalization of Life sciences companies: the India paradigm’. The…
The first compulsory license by the Indian government: boon or Bane?
April 2012: This is indeed good news for the burgeoning middle class who could now afford the drug for their treatment. However there are many questions that are unanswered. It’s true that reducing the price by 97% will definitely help…
The keys to successful implementation of a telemedicine program
January 2012 For a telemedicine program to be successful, the right environment is necessary in order to guarantee the implementation. Aspects such as human commitment and acceptance by clinicians and patients, technological aspects such as development of infrastructures, economic and…
Can telemedicine help ophthalmologists reduce visual impairment in Age-related...
December 2011 Telemedicine may be a very effective tool in the ophthalmic health care programs set up, as well as many others, in particular for those countries with remote and isolated areas, and it is a very good business opportunity…
Can rapid tests for infectious disease contribute to the rational use of...
November 2011: Can rapid tests for infectious disease contribute to the rational use of antibiotics? Thanks to the use of such diagnostic tests, the specialists in primary care or family physicians can have very valuable additional information that helps them…
The In Vitro Molecular Diagnostic market
October 2011: The In Vitro Molecular Diagnostic market India, one of the leading countries with the greatest potential for developing bio-industry and manufacturing diagnostic IVD systems, need to invest in research and development to compete in the international market and…
